[B041] 靶点竞争格局

get
https://connect.zhihuiya.com/synapse/target/analysis
在体验中心中试用

获取靶点竞争格局，包括机构、适应症、药物类型等

请求参数

此 API 接口支持的参数列表

名称类型示例描述
target_id
必填
string9786d32e3d244a688ec6a60d2fe1b10b
靶点id，通过靶点自动补全接口获取
type
必填
stringORGANIZATION
分析类型，枚举值：ORGANIZATION、DISEASE、DRUG_TYPE
roll_up
必填
booleantrue
是否从总公司为根节点开始聚合，true-是，false -否。默认true

响应结构

API 响应数据的结构说明

字段名类型示例描述
data
object-
响应数据
disease
array[ { "id": "524236920ce94d7d831f0ac59bcacae8", "phase": [ { "dev_status": { "display_name": [ { "lang": "EN", "name": "Approved" }, { "lang": "CN", "name": "批准上市" } ], "normalized_id": "efd6215835394b07b046125e3175d3fe" }, "drug_count": 7 } ], "display_name": [ { "lang": "EN", "name": "Hodgkin's Lymphoma" }, { "lang": "CN", "name": "霍奇金淋巴瘤" } ] } ]
适应症，引用“AnalysisDto”
id
stringb4c624212749f84e83429c5a8673c692
ID
phase
array[ { "dev_status": { "display_name": [ { "lang": "EN", "name": "Pending" }, { "lang": "CN", "name": "无进展" } ], "normalized_id": "4d95bf5fb0c340fbb38cda626c1c9c60" }, "drug_count": 10 } ]
研发阶段，引用“PhaseDto”
dev_status
object{ "display_name": [ { "lang": "EN", "name": "Pending" }, { "lang": "CN", "name": "无进展" } ], "normalized_id": "4d95bf5fb0c340fbb38cda626c1c9c60" }
研发状态
display_name
array[ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ]
字典名称
lang
stringEN
语言
name
stringRanibizumab (Genentech)
药物、靶点、机构、适应症、国家/地区、字典、作用机制 名称
normalized_id
string2fbfdb3e92d942c48cbb0adb79f23526
字典ID
drug_count
integer<int64>10
药物数量
display_name
array[ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ]
名称，引用“CommonName”
drug_type
array[ { "id": "c38eb408d6b842f487d6a27484156633", "phase": [ { "dev_status": { "display_name": [ { "lang": "EN", "name": "Approved" }, { "lang": "CN", "name": "批准上市" } ], "normalized_id": "efd6215835394b07b046125e3175d3fe" }, "drug_count": 14 } ], "display_name": [ { "lang": "EN", "name": "Monoclonal antibody" }, { "lang": "CN", "name": "单克隆抗体" } ] } ]
药物类型，引用“AnalysisDto”
organization
array[ { "id": "391046f8744a1cde275e09de08b483f3", "phase": [ { "dev_status": { "display_name": [ { "lang": "EN", "name": "Approved" }, { "lang": "CN", "name": "批准上市" } ], "normalized_id": "efd6215835394b07b046125e3175d3fe" }, "drug_count": 2 } ], "display_name": [ { "lang": "EN", "name": "Akeso Biopharma Co., Ltd." }, { "lang": "CN", "name": "中山康方生物医药有限公司" } ] } ]
机构，引用“AnalysisDto”
status
必填
booleanfalse
状态
error_msg
stringThe request parameter format is incorrect！
错误信息
error_code
必填
integer0
错误代码

成功响应示例

成功调用 API 的响应示例

JSON 
{
  "data": {
    "disease": [
      {
        "id": "b4c624212749f84e83429c5a8673c692",
        "phase": [
          {
            "dev_status": {
              "display_name": [
                {
                  "lang": "EN",
                  "name": "Ranibizumab (Genentech)"
                }
              ],
              "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
            },
            "drug_count": 10
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "drug_type": [
      {
        "id": "b4c624212749f84e83429c5a8673c692",
        "phase": [
          {
            "dev_status": {
              "display_name": [
                {
                  "lang": "EN",
                  "name": "Ranibizumab (Genentech)"
                }
              ],
              "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
            },
            "drug_count": 10
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "organization": [
      {
        "id": "b4c624212749f84e83429c5a8673c692",
        "phase": [
          {
            "dev_status": {
              "display_name": [
                {
                  "lang": "EN",
                  "name": "Ranibizumab (Genentech)"
                }
              ],
              "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
            },
            "drug_count": 10
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ]
  },
  "status": true,
  "error_code": 0
}

错误码

此接口可能返回的错误码列表

业务错误码

错误码描述
68300004请求参数异常!
68300005查询Api失败!
68300006解析基本存取错误!
68300007存在错误的请求!
68300008服务中断异常，请稍后再试!
68300010文件不符合上传规范!

平台错误码

错误码描述
67200001API整体限流错误!
67200002用户调用请求限流限制错误!
67200003申请token的key和secret不正确或者状态错误!
67200004无权限或该接口的套餐已超过系统设置的上限!
67200005账户余额不足，调用失败!
67200006客户端已过期，调用失败!
67200007超过调用额度，调用失败!

HTTP 状态码

状态码描述
0请求成功
401Unauthorized
403Forbidden
404Not Found

性能指标

此接口的预期性能特征

正常响应时间

5000 ms

最大响应时间

10000 ms